TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.070
-0.050 (-1.21%)
Nov 20, 2024, 4:00 PM EST - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $124.10 million as of November 21, 2024. Its market cap has increased by 12.01% in one year.
Market Cap
124.10M
Enterprise Value
136.26M
1-Year Change
12.01%
Ranking
Category
Stock Price
$4.07
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $124.10M, a decrease of -62.25%. That is a compound annual growth rate of -22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 124.10M | -44.19% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | 328.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensus Healthcare | 125.21M |
| Candel Therapeutics | 123.41M |
| Innate Pharma | 122.98M |
| Alto Neuroscience | 121.91M |
| Elutia | 121.25M |
| Akoya Biosciences | 119.45M |
| Puma Biotechnology | 118.79M |
| Adlai Nortye | 115.13M |